AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Amylyx Stockholders and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims... Read more.
ROCKLEY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Rockley Photonics Holdings Limited and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action... Read more.
Samsara Unveils Innovative Solutions Tailored for Mexico’s Thriving Transportation Industry at Expo Transporte 2023 in Guadalajara
MEXICO CITY–(BUSINESS WIRE)–Samsara Inc. (“Samsara”) (NYSE: IOT), the pioneer of the Connected Operations™ Cloud, is excited to announce... Read more.
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action... Read more.
FISKER ALERT: Bragar Eagel & Squire, P.C. is Investigating Fisker Inc. on Behalf of Fisker Stockholders and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims... Read more.
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action... Read more.
EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SMR
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers... Read more.
SEE Announces Expiration and Results of Offer to Purchase 5.125% Senior Notes due 2024
CHARLOTTE, N.C.–(BUSINESS WIRE)–Sealed Air Corporation (“SEE”) (NYSE: SEE) today announced that its previously announced cash tender offer... Read more.
Ooma Schedules Release of Third Quarter Fiscal 2024 Results
SUNNYVALE, Calif.–(BUSINESS WIRE)–Ooma, Inc. (NYSE: OOMA), a smart communications platform for businesses and consumers, plans to release its financial... Read more.
U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)
The approval is based on the pivotal TRIDENT-1 trial, in which Augtyro successfully achieved a high objective response rate and durable response1 Augtyro adds to... Read more.